⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Recover Investment Losses: Class Action Initiated Against Regeneron Pharmaceuticals, Inc. (REGN)
accessnewswire.com
REGN
Regeneron Pharmaceuticals, Inc. (REGN) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of September 14, 2026 Deadline
accessnewswire.com
REGN
Levi & Korsinsky Notifies Regeneron Pharmaceuticals, Inc. (REGN) Shareholders of Class Action Lawsuit and September 14, 2026 Deadline
accessnewswire.com
REGN
Tessera Therapeutics Appoints Joseph Romanelli as President and Chief Executive Officer
prnewswire.com
REGN
MRK
ALK Inhibitors Market Set for Transformational Growth at a CAGR of 4% During the Forecast Period (2026-2036) Backed by Next-Generation Targeted Therapies| DelveInsight
prnewswire.com
PFE
MRK
LLY
AMGN
BMY
NVS
GILD
AZN
REGN
SNY
TEVA
IMUX
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of September 14, 2026 in Regeneron Pharmaceuticals, Inc. Lawsuit - REGN
prnewswire.com
REGN
REGN Shareholder Alert: Regeneron Pharmaceuticals, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky
businesswire.com
REGN
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - REGN
prnewswire.com
REGN
INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. (REGN) Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit
prnewswire.com
REGN
REGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Pharmaceuticals, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
REGN